Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer
| العنوان: | Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer |
|---|---|
| المؤلفون: | Luis García Ruiz, Jorge Luna-Abanto, Manuel Álvarez Larraondo, Vladimir Villoslada Terrones, Jheff Laura Martinez |
| المصدر: | Journal of Gynecologic Surgery |
| بيانات النشر: | Mary Ann Liebert, Inc., publishers, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Advanced ovarian cancer, medicine.medical_specialty, 030219 obstetrics & reproductive medicine, business.industry, Mortality rate, Obstetrics and Gynecology, Mean age, Original Articles, medicine.disease, liver, Metastasis, Resection, Surgery, 03 medical and health sciences, 0302 clinical medicine, ovarian cancer, 030220 oncology & carcinogenesis, medicine, cytoreductive surgery, metastasis, Stage (cooking), business, Cytoreductive surgery, Ovarian cancer |
| الوصف: | Objective: The aim of this study was to describe and evaluate the safety of hepatic resections for ovarian cancer liver metastases and the benefit in terms of survival as part of cytoreductive surgery among peritoneal seeding and parenchymal metastases. Materials and Methods: Data were reviewed retrospectively from patients who underwent liver resection as part of cytoreductive surgery for ovarian cancer at the Instituto Nacional de Enfermedades Neoplasicas, in Lima, Peru, from January 2009 to December 2017. Results: From January 2009 to December 2017, 1211 patients underwent surgical cytoreduction for ovarian cancer; 39 of these patients had liver resection as part of their surgical treatment, with 9, 17, and 13 patients receiving primary, secondary, and tertiary, resections, respectively. The mean age of the patients was 46, the majority (87%) had stage III/IV ovarian cancer. In addition, 21 patients had parenchymal metastasis resections, and 95% of the patients had Dindo-Clavien I and II grade complications. The 30-day mortality rate was 0. Conclusions: Liver resection for advanced ovarian cancer is a safe procedure for primary up to quaternary cytoreduction and may confer survival benefits to patients. |
| اللغة: | English |
| تدمد: | 1557-7724 1042-4067 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320132ee32be8834fe5c898b0dff549c http://europepmc.org/articles/PMC7153635 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....320132ee32be8834fe5c898b0dff549c |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15577724 10424067 |
|---|